Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Open in API
Filings indexed 638 across all filing types
Latest filing 2021-08-16 Regulatory Filings
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2021-08-16 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-08-16 English
News release - English.pdf
Regulatory Filings
2021-08-16 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a press release announcing the completion of enrollment in a Phase 4 clinical trial for a drug (IXINITY®) by Medexus Pharmaceuticals. It discusses the trial's purpose, expected completion, potential label expansion, and market opportunity. There is no financial data, regulatory filing, or detailed report content. The document is an update on clinical trial progress and company plans, typical of a Capital/Financing Update or general corporate announcement. However, since it focuses on clinical trial enrollment completion and future milestones rather than financing or capital structure changes, it does not fit CAP. It is not a regulatory filing or report publication announcement either. Given the content, the best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2021-08-12 English
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing that Medexus Pharmaceuticals will present at the SNN Network Summer Virtual Event on August 19, 2021. It includes details about the event, how to access the webcast, and company background information. There is no financial data, no detailed presentation content, no report attached or referenced as being published, and no regulatory or voting information. The document is essentially an announcement of an upcoming investor presentation event, not the presentation itself or a financial report. Therefore, the most appropriate classification is Investor Presentation (IP), as it relates to a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation content is not included here, the announcement is about the presentation event.
2021-08-10 English
News release - English.pdf
Call Transcript Classification · 80% confidence The document is a press release announcing the scheduling of a conference call to discuss the company's first quarter fiscal 2022 financial results and corporate progress. It mentions the date and time of the call, how to access it, and that the financial statements and MD&A will be filed separately. There is no actual financial data or detailed report content in this document. It is clearly an announcement about an upcoming earnings call, not the call transcript itself or the financial report. Therefore, the document fits best into the category of Call Transcript announcements or scheduling, which aligns with the Call Transcript (CT) category as it relates to the conference call content. However, since this is only scheduling information and not the transcript itself, the closest appropriate category is Call Transcript (CT) with moderate confidence due to the nature of the announcement being about the call.
2021-08-10 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.